Leading Edge Pharms, Inc. (LEP) is a biotechnology company focused on the research, development and commercialization of novel cannabinoid therapies and innovative delivery platforms. LEP is the developer of CANNAVERA™ pain relief products, available in pharmacies across the United States. All LEP products are manufactured in FDA registered facilities adhering to current Good Manufacturing Practices and are available at www.LENCURA.com.
Leading Edge Pharms Opens CBD Research and Innovation Center, LENCURA Labs Leading Edge Pharms CSO Dr. Daniel Holsworth to Oversee R&D HENDERSON, Nevada, March 26, 2019 /PRNewswire/ -- Leading Edge Pharms, Inc., (LEP) a biotechnology company developing [...]
Leading Edge Appoints Dr. Daniel Holsworth as CSO to Head Up Clinical CBD Research Holsworth to lead clinical research efforts and product development of new CBD solutions HENDERSON, Nevada, March 4, 2019 /PRNewswire/ -- Leading Edge Pharms, [...]
Study by Tioga Research Supports Efficacy of Leading Edge Pharms' Liposomal Compound Silvidiol™ Topical Cannabinoid Delivery System Demonstrates Ability to Permeate Skin to Reach Somatic and Neuropathic Sensory Receptors Without Systemic Exposure [...]
Leading Edge Pharms Adds New Pain Relief Ointment to CANNAVERA™ Product Line New Silvidiol™ infused ointment ideal for pain relief and healthy skin maintenance HENDERSON, Nevada, Jan. 29, 2019 /PRNewswire/ -- Leading Edge Pharms, Inc. (LEP), a [...]
CARE Pharmacies and Leading Edge Pharms to Expand Access to Opioid Alternatives for Pain Management CARE Pharmacies to offer CANNAVERA™ Topical Pain Relief products to its association member pharmacies nationwide Henderson NV, [...]
Direct Investment Opportunity Inquiries to